These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 28877395)
1. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome? Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395 [TBL] [Abstract][Full Text] [Related]
2. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation? Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416 [TBL] [Abstract][Full Text] [Related]
3. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention. Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285 [TBL] [Abstract][Full Text] [Related]
4. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention. Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643 [TBL] [Abstract][Full Text] [Related]
5. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317 [TBL] [Abstract][Full Text] [Related]
6. The value of urodynamic tools to guide patient selection in sacral neuromodulation. Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936 [TBL] [Abstract][Full Text] [Related]
8. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique. Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466 [TBL] [Abstract][Full Text] [Related]
9. Medium-term experience of sacral neuromodulation by tined lead implantation. Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350 [TBL] [Abstract][Full Text] [Related]
10. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation. Vaganée D; Kessler TM; Van de Borne S; De Win G; De Wachter S BJU Int; 2019 May; 123(5A):E7-E13. PubMed ID: 30537223 [TBL] [Abstract][Full Text] [Related]
11. Screening for depression and anxiety in patients with storage or voiding dysfunction: A retrospective cohort study predicting outcome of sacral neuromodulation. Drossaerts J; Vrijens D; Leue C; Schilders I; Van Kerrebroeck P; van Koeveringe G Neurourol Urodyn; 2016 Nov; 35(8):1011-1016. PubMed ID: 26351817 [TBL] [Abstract][Full Text] [Related]
12. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation. Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126 [TBL] [Abstract][Full Text] [Related]
13. Sacral Neuromodulation: Standardized Electrode Placement Technique. Matzel KE; Chartier-Kastler E; Knowles CH; Lehur PA; Muñoz-Duyos A; Ratto C; Rydningen MB; Sørensen M; van Kerrebroeck P; de Wachter S Neuromodulation; 2017 Dec; 20(8):816-824. PubMed ID: 28975677 [TBL] [Abstract][Full Text] [Related]
14. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?]. Hoda MR; Fornara P Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609 [TBL] [Abstract][Full Text] [Related]
15. Prolonged percutaneous SNM testing does not cause infection-related explanation. Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331 [TBL] [Abstract][Full Text] [Related]
16. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study. Kaaki B; Gupta D PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082 [TBL] [Abstract][Full Text] [Related]
17. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment. Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157 [TBL] [Abstract][Full Text] [Related]
18. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526 [TBL] [Abstract][Full Text] [Related]
19. The effect of sacral neuromodulation on pudendal nerve function and female sexual function. Parnell BA; Howard JF; Geller EJ Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871 [TBL] [Abstract][Full Text] [Related]
20. Long-term results of sacral neuromodulation with the tined lead procedure. Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]